Immunotherapy for Neuroblastoma by Hematopoietic Cell Transplantation and Post-transplant Immunomodulation

The authors oversee the potential benefit of reinforcement of immunotherapy for neuroblastoma following hematopoietic cell transplantation, focusing primarily on lymphocytes and dendritic cells.